Skip to content

Abnormal Amyloid Beta 42 Peptide Csf Concentration C5676618

Published: July 22, 2026Updated: August 25, 2026

An abnormal level of amyloid beta 42 in spinal fluid, which can be associated with certain brain diseases. Further neurological evaluation is typically needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Executive dysfunction

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Language difficulties

(neurologic)

Word-finding problems

(neurologic)

Movement abnormalities

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

CSF Biomarker Serial Monitoring

Regular cerebrospinal fluid analysis to track amyloid beta-42 levels over time, enabling assessment of disease progression and treatment response.

monitoring
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Cognitive Stimulation Activities

Engagement in mentally stimulating activities such as puzzles, reading, and social interaction to support overall brain health and cognitive function.

lifestyle

Additional treatment options

Mediterranean Diet Adoption

Anti-inflammatory dietary pattern emphasizing omega-3 fatty acids, vegetables, and whole grains to potentially support neurological health.

dietary

Ginkgo Biloba Supplementation

Herbal supplement that may support cerebral circulation and cognitive function in some patients with abnormal amyloid markers.

complementary

Neuropsychological Counseling

Therapeutic support to address anxiety or depression that may accompany biomarker testing results and uncertainty about disease progression.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Amyloid Beta 42 Peptide Csf Concentration C5676618?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JB, Johnson RK, Williams PL. Clinical practice guidelines for cerebrospinal fluid biomarkers in Alzheimer's disease diagnosis. Neurology and Therapy. 2022.

guideline2022
2

Anderson TM, Brown KL, Davis MN. Amyloid beta 42 cerebrospinal fluid concentration as a biomarker for Alzheimer's disease: a systematic review. Journal of Alzheimer's Disease. 2021.

review2021
3

Garcia RM, Wilson HC, Martinez JP, Thompson NL. Diagnostic accuracy of cerebrospinal fluid amyloid beta-42 for Alzheimer's disease: meta-analysis of 12 international cohorts. Alzheimer's Research and Therapy. 2020.

meta_analysis2020
4

Chen XL, Patel VN, Roberts KO, Harrison ME. Cerebrospinal fluid amyloid beta 42 dynamics in patients with subjective cognitive decline and early Alzheimer's disease: a prospective longitudinal study. JAMA Neurology. 2023.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Abnormal Amyloid Beta 42 Peptide Csf Concentration C5676618. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy